Payal Kiran Parikh

Title: Payal Kiran Parikh: Innovator in Anticancer Research

Introduction

Payal Kiran Parikh is a prominent inventor based in Bengaluru, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with potential anticancer properties. With a total of 2 patents to her name, her work is paving the way for new therapeutic options.

Latest Patents

Her latest patents include the development of tricyclic fused pyridin-2-one derivatives, which are recognized for their use as BRD4 inhibitors. The present disclosure describes heterocyclic compounds of Formula I, including their stereoisomers, pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, racemic mixtures, optically active forms, and pharmaceutically active derivatives. These compounds have been characterized to exhibit high anticancer activity and are useful as medicaments for the treatment, prevention, or suppression of diseases mediated by one or more BET family of bromodomains.

Career Highlights

Payal Kiran Parikh is currently associated with Jubilant Biosys Limited, where she continues to innovate in the field of drug development. Her research focuses on synthesizing and characterizing compounds that can lead to effective cancer treatments.

Collaborations

She collaborates with notable colleagues, including Saravanan Vadivelu and Sridharan Rajagopal, to advance her research and contribute to the scientific community.

Conclusion

Payal Kiran Parikh's work in developing novel anticancer compounds highlights her dedication to improving healthcare through innovation. Her contributions are significant in the ongoing fight against cancer, and her patents reflect her expertise and commitment to the field.